Among sectors, except IT all other indices are trading in the red.
Zydus to launch novel biologic for rabies:
Zydus has received marketing authorization for TwinrabTM (RabiMabs) from the Drug Controller General of India.
The novel biologic which will be marketed under the brand name, TwinrabTM, is indicated in combination with rabies vaccine for rabies post-exposure prophylaxis.
The United States Food and Drug Administration (USFDA) has granted an orphan drug status to this candidate.
Tata Steel to sale Europe assets: Shares of Tata Steel declined nearly 4 percent on September 3 after the company announced the sale of its European business.
KNR Constructions wins order worth Rs 850cr: Shares of KNR Constructions gained nearly 3 percent on September 3 after the company won an order worth Rs 850 crore.
Mcx Tips Provider
For Quick Trial – 62329-95233 |
or mail us here:info@thegrssolution.com
or visit www.thegrssolution.com
For Quick Trial – 62329-95233 |
or mail us here:info@thegrssolution.com
or visit www.thegrssolution.com